Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
03/20/2003 | WO2001078894A3 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
03/20/2003 | WO1999049294A3 Assay methods |
03/20/2003 | US20030056235 Inhibition of gene expression in cells; obtain celss, transform with ribonucleic acids, monitor and detect adjustment in gene expression, adjustment in gene expression indicates gene expression inhibition |
03/20/2003 | US20030056234 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of myocardial infarction, atherosclerosis and cardiovascular disorders |
03/20/2003 | US20030055239 Human receptor tyrosine kinase, KDR |
03/20/2003 | US20030055236 Secreted protein HKABT24 |
03/20/2003 | US20030055232 Nucleotide sequences coding enzymatic polypeptide for use in the generation of lysine |
03/20/2003 | US20030055222 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/20/2003 | US20030055215 Calcium-binding protein for use in the treatment of inflammation, tumors and skin disorders |
03/20/2003 | US20030055020 Introducing ribonucleic acid (RNA) into cell in an amount sufficient to inhibit expression of target gene, wherein RNA comprises a double-stranded structure with an identical nucleotide sequence as compared to portion of target gene |
03/20/2003 | US20030054993 For contraception in a mammal, for therapy of infertility |
03/20/2003 | US20030054992 Therapy |
03/20/2003 | US20030054959 Pre-emergent biological control agents |
03/20/2003 | US20030054934 Method and apparatus for the concentration of fluid-borne pathogens |
03/20/2003 | US20030054554 Albumin derivatives with therapeutic functions |
03/20/2003 | US20030054539 Enzymatic polypeptide for use in paper making, detergents and textile processing |
03/20/2003 | US20030054537 Genetically engineered bacteria for use as tools in the generation of heterologous proteins |
03/20/2003 | US20030054534 Nucleotide sequences coding polypeptide for use in detergentgs, textile treatment, papermaking, deinking and drain cleaning |
03/20/2003 | US20030054528 Mitogen-activated protein kinase p38-2 and methods of use therefor |
03/20/2003 | US20030054525 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R / (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3 |
03/20/2003 | US20030054523 Isoprenoid production |
03/20/2003 | US20030054520 Recombinant enzymes having improved NAD (H) affinity |
03/20/2003 | US20030054519 Pseudomonas microorganism for use in the generation of indigo |
03/20/2003 | US20030054518 Novel xylanase from trichoderma reesei, method for production thereof, and methods employing this enzyme |
03/20/2003 | US20030054506 Method of producing L-lysine |
03/20/2003 | US20030054504 Genetically engineered microorganism for use in the generation of 5'-inosinic acid |
03/20/2003 | US20030054503 Generation of threonine; obtain genetically engineered microorganism coding threonine, ferment, recover threonine |
03/20/2003 | US20030054502 Generation of pantothenic acid and/or a salt; obtain microorganism coding pantothenic acid or salt, ferment and recover pantothenic acid or salt |
03/20/2003 | US20030054499 Microorganism producing frutosyl transferase and method for producing fructooligosaccharides and neofructooligosaccharides using the same |
03/20/2003 | US20030054494 Novel chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same |
03/20/2003 | US20030054493 Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease |
03/20/2003 | US20030054492 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
03/20/2003 | US20030054491 Peptide for use in the treatment of immunological, infectious and cancer disorders |
03/20/2003 | US20030054490 Isolated human phosphatase proteins, nucleic acid molecules encoding phosphatase proteins and uses thereof |
03/20/2003 | US20030054488 Goodpasture antigen binding protein |
03/20/2003 | US20030054452 Lysolipid for use in controlling apoptosis and treating inflammatory and innumological disorders |
03/20/2003 | US20030054448 T1R taste receptors and genes encoding same |
03/20/2003 | US20030054447 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/20/2003 | US20030054446 Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379 |
03/20/2003 | US20030054445 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
03/20/2003 | US20030054444 Nucleotide sequences coding polypeptide for use in the treatment of aberrant cell propagation and nervous system disorders |
03/20/2003 | US20030054439 Truncated soluble tumor necrosis factor type-I and type-II receptors |
03/20/2003 | US20030054436 Staphylococcus aureus polynucleotides and sequences |
03/20/2003 | US20030054435 Generating cell extract from cultured cells; obtain cultured cells, incubate with lysis agent, recover and analyze cellular components |
03/20/2003 | US20030054409 Novel complex-forming proteins |
03/20/2003 | US20030054398 Isolated human aminotransferase proteins, nucleic acid molecules encoding aminotransferase proteins and uses thereof |
03/20/2003 | US20030054391 Nucleotide sequences coding polypeptide for use in biological pest control |
03/20/2003 | US20030054380 Diagnosing long qt syndrome; obtain sample, extract nucleotide sequences, incubate with probe, detect polymorphism, presence of polymorphism indicates long qt syndrome |
03/20/2003 | US20030054014 Administering fungi spores; aging resistance |
03/20/2003 | US20030054013 Tuberculosis therapy; anticancer agents |
03/20/2003 | US20030054011 Anticancer agents |
03/20/2003 | US20030054008 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
03/20/2003 | US20030054003 Antitumor agents, anticarcinogenic agents |
03/20/2003 | US20030054001 Antibody, antigen complex |
03/20/2003 | US20030053999 Enzyme with xylanase activity |
03/20/2003 | US20030053990 Virus vectors and methods of making and administering the same |
03/20/2003 | US20030053988 Genetic engineering; culture product; process control |
03/20/2003 | US20030053984 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
03/20/2003 | CA2461692A1 Use of a protein of the crmp family for treating diseases related to the immune system |
03/20/2003 | CA2460509A1 Synthetic hcv envelope proteins and their use for vaccination |
03/20/2003 | CA2460425A1 Novel nucleic acids and polypeptides |
03/20/2003 | CA2459426A1 Human immunodeficiency virus envelope glycoprotein mutants and uses thereof |
03/20/2003 | CA2459367A1 Methods for construction and screening of libraries of chemokine variants |
03/20/2003 | CA2455990A1 Methods for diagnosing and treating diseases and conditions associated with protein kinase c.lambda. |
03/20/2003 | CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
03/20/2003 | CA2451254A1 Novel proteins and nucleic acids encoding same |
03/19/2003 | EP1293567A1 Ligand to gpr8 and dna thereof |
03/19/2003 | EP1293562A1 Fungal glyoxal oxidases |
03/19/2003 | EP1293560A2 Methods for producing L-lysine and L-glutamic acid by fermentation |
03/19/2003 | EP1293514A1 Multimeric single chain tandem Fv-antibodies |
03/19/2003 | EP1293512A2 DNA encoding the baboon and cynomolgus macaque prostaglandin E2 receptor EP4 subtype |
03/19/2003 | EP1292827A1 T2r taste receptors and genes encoding same |
03/19/2003 | EP1292689A1 Regulated gene expression in yeast and methods of use |
03/19/2003 | EP1292688A2 Promoters for regulated gene expression |
03/19/2003 | EP1292687A2 Regulated antigen delivery system (rads) involving bacteria |
03/19/2003 | EP1292685A2 Human lyases |
03/19/2003 | EP1292684A2 Proteases |
03/19/2003 | EP1292683A2 Secreted redox proteins |
03/19/2003 | EP1292682A2 Method for the production of p-hydroxybenzoate in species of pseudomonas and agrobacterium |
03/19/2003 | EP1292681A1 Antigenic polypeptides |
03/19/2003 | EP1292679A1 A g-protein coupled receptor |
03/19/2003 | EP1292678A2 G-protein coupled receptors |
03/19/2003 | EP1292676A1 Mutation associated with epilepsy |
03/19/2003 | EP1292674A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
03/19/2003 | EP1292669A1 Novel bacillus sp. wl-1 strain producing mannanase |
03/19/2003 | EP1292668A2 Gene disruption methodologies in fungi for drug target discovery |
03/19/2003 | EP1292667A2 Identification and use of molecular markers indicating cellular reprogramming |
03/19/2003 | EP1292620A2 Nuclear hormone receptor |
03/19/2003 | EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
03/19/2003 | EP1292617A1 Novel compounds |
03/19/2003 | EP1292616A2 Nucleic acids encoding a regulator of g protein signaling, rgs18, and uses thereof |
03/19/2003 | EP1292613A2 Chimeric gfp-aequorin as bioluminescent ca?++ reporters at the single cell level |
03/19/2003 | EP1147063B1 Process for the treatment of waste water containing heavy metals |
03/19/2003 | EP1002122B1 Process for preparing amides |
03/19/2003 | EP0937156B1 Preparation of d-amino acids by direct fermentative means |
03/19/2003 | EP0771868B1 Novel deaminoneuraminidase and process for producing the same |
03/19/2003 | EP0711350B1 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
03/19/2003 | EP0711348B1 Process for the efficient production of 7-adca via 3-(carboxyethylthio)propionyl-7-adca |
03/19/2003 | EP0677104B1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
03/19/2003 | EP0595935B1 Papillomavirus Vaccine |